ABIRATERONE ACETATE + Prednisone for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 5 Feb 2013: Trial started, NCT01786265
  2. 7 Feb 2013: Trial registered, NCT01786265

The trials

NCT01786265: Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer

State
Under way
Phase
Phase 2
People
310 planned
Started
5 Feb 2013
Primary completion
1 Feb 2027
Arms
Arm B (finite androgen ablation, abiraterone, prednisone)
Results
None posted
  1. 5 Feb 2013: Trial started
  2. 7 Feb 2013: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.